These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 38052985)

  • 1. A multiple hits hypothesis for memory dysfunction in Parkinson disease.
    Citro S; Lazzaro GD; Cimmino AT; Giuffrè GM; Marra C; Calabresi P
    Nat Rev Neurol; 2024 Jan; 20(1):50-61. PubMed ID: 38052985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cognitive impairment in patients with Parkinson disease].
    Abe N; Mori E
    Brain Nerve; 2012 Apr; 64(4):321-31. PubMed ID: 22481505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?
    Cinar E; Yalcin-Cakmakli G; Saka E; Ulusoy A; Yuruker S; Elibol B; Tel BC
    Exp Neurol; 2020 Aug; 330():113357. PubMed ID: 32437708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson's Disease.
    Oosterveld LP; Kuiper TI; Majbour NK; Verberk IMW; van Dijk KD; Twisk JWR; El-Agnaf OM; Teunissen CE; Weinstein HC; Klein M; Berendse HW; van de Berg WDJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal α-synuclein pathology correlates with memory impairment in multiple system atrophy.
    Miki Y; Foti SC; Hansen D; Strand KM; Asi YT; Tsushima E; Jaunmuktane Z; Lees AJ; Warner TT; Quinn N; Ling H; Holton JL
    Brain; 2020 Jun; 143(6):1798-1810. PubMed ID: 32385496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cognitive impairment in Parkinson's disease].
    Tachibana H
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1142-9. PubMed ID: 24450147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory impairment in Parkinson's disease: The retrieval versus associative deficit hypothesis revisited and reconciled.
    Bezdicek O; Ballarini T; Buschke H; Růžička F; Roth J; Albrecht F; Růžička E; Mueller K; Schroeter ML; Jech R
    Neuropsychology; 2019 Mar; 33(3):391-405. PubMed ID: 30816784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease.
    Ibarretxe-Bilbao N; Junque C; Marti MJ; Tolosa E
    J Neurol Sci; 2011 Nov; 310(1-2):70-4. PubMed ID: 21864849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological correlates of prospective memory: A comparison between tremor-dominant Parkinson's disease and cervical dystonia.
    D'Iorio A; Esposito M; Maggi G; Amboni M; Vitale C; Santangelo G
    J Clin Neurosci; 2021 May; 87():156-161. PubMed ID: 33863525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between executive function and verbal memory in Parkinson's disease.
    Higginson CI; King DS; Levine D; Wheelock VL; Khamphay NO; Sigvardt KA
    Brain Cogn; 2003 Aug; 52(3):343-52. PubMed ID: 12907179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
    Wang N; Zhang L; Yang H; Luo X; Fan G
    Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.
    Crowley SJ; Banan G; Amin M; Tanner JJ; Hizel L; Nguyen P; Brumback B; Rodriguez K; McFarland N; Bowers D; Ding M; Mareci TA; Price CC
    J Parkinsons Dis; 2021; 11(1):283-297. PubMed ID: 33216042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associative reinstatement memory measures hippocampal function in Parkinson's Disease.
    Cohn M; Giannoylis I; De Belder M; Saint-Cyr JA; McAndrews MP
    Neuropsychologia; 2016 Sep; 90():25-32. PubMed ID: 27133526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease.
    Nobili F; Arnaldi D; Campus C; Ferrara M; De Carli F; Brugnolo A; Dessi B; Girtler N; Morbelli S; Abruzzese G; Sambuceti G; Rodriguez G
    Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2209-18. PubMed ID: 21744112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.
    Bohnen NI; Albin RL; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Frey KA
    JAMA Neurol; 2015 Feb; 72(2):194-200. PubMed ID: 25506674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study.
    Manchinu MF; Pala M; Palmas MF; Diana MA; Maschio A; Etzi M; Pisanu A; Diana FI; Marongiu J; Mansueto S; Carboni E; Fusco G; De Simone A; Carta AR
    Exp Neurol; 2024 Feb; 372():114651. PubMed ID: 38092188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.